Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays
L Wang, L Chen, M Yu, LH Xu, B Cheng, YS Lin… - Scientific reports, 2016 - nature.com
… of cell growth inhibition by compound 17, … inhibitors identified in the present study provided
valuable alternatives for further development into therapeutic candidates for cancer treatment. …
valuable alternatives for further development into therapeutic candidates for cancer treatment. …
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
GM Nitulescu, D Margina… - International …, 2016 - spandidos-publications.com
… An isosteric scaffold of adenosine, the 4-aminopyrido[2,3-d]pyrimidine derivative API-1 was
discovered to inhibit Akt by screening the DTP/NCI compound library in a cell-based assay. …
discovered to inhibit Akt by screening the DTP/NCI compound library in a cell-based assay. …
Computational Evaluation of Bioactive Compounds from Colocasia affinis Schott as a Novel EGFR Inhibitor for Cancer Treatment
TA Balogun, N Ipinloju, OT Abdullateef… - Cancer …, 2021 - journals.sagepub.com
… EGFR inhibitors and FDA-approved drugs for cancer treatment. EGFR inhibitors function
either … The theoretical methods employed to compare the chemical and biological activities of …
either … The theoretical methods employed to compare the chemical and biological activities of …
Melatonin: a new inhibitor agent for cervical cancer treatment
R Shafabakhsh, RJ Reiter, H Mirzaei… - Journal of cellular …, 2019 - Wiley Online Library
… Current treatment options often have severe side effects and … Melatonin is an indolamine
compound secreted from the … improve the therapeutic impacts of different anticancer drugs. Thus…
compound secreted from the … improve the therapeutic impacts of different anticancer drugs. Thus…
[PDF][PDF] Invention of (Gluta. Sulfazane-Cefixime) Compounds as Inhibitors of Cancerous Tumors
IKA Alsabri, HK Abdullabass… - … Disease Research, 2020 - researchgate.net
… of treatment such as new drugs, new methods of … inhibition of cancer cells (Throat Cancer)
for all innovative pharmaceutical compounds that prepared in this research, and compound{2} …
for all innovative pharmaceutical compounds that prepared in this research, and compound{2} …
[HTML][HTML] Curcumin as tyrosine kinase inhibitor in cancer treatment
A Golonko, H Lewandowska, R Świsłocka… - European Journal of …, 2019 - Elsevier
… Many years of research allowed a thorough analysis of the mechanism of tyrosine … new
therapeutic methods using synthetic chemical compounds with the properties of kinase inhibitors. …
therapeutic methods using synthetic chemical compounds with the properties of kinase inhibitors. …
Dual inhibitors as a new challenge for cancer multidrug resistance treatment
T Stanković, J Dinić, A Podolski-Renić… - Current Medicinal …, 2019 - ingentaconnect.com
… designed to target microtubules and other targets within cancer cell, compounds that target
… inhibitor approved for cancer treatment, specifically advanced non–small cell lung cancer (…
… inhibitor approved for cancer treatment, specifically advanced non–small cell lung cancer (…
The search for potent, small‐molecule HDACIs in cancer treatment: a decade after vorinostat
C Zagni, G Floresta, G Monciino… - Medicinal research …, 2017 - Wiley Online Library
… These compounds demonstrated significant HDAC inhibitory activities and antiproliferative
… was 15l that resulted equipotent to SB939 in cancer cell growth and also in HDAC inhibition…
… was 15l that resulted equipotent to SB939 in cancer cell growth and also in HDAC inhibition…
New approaches and procedures for cancer treatment: Current perspectives
DT Debela, SGY Muzazu, KD Heraro… - SAGE open …, 2021 - journals.sagepub.com
… and therapeutic options. Targeted therapy possessed breakthrough potential inhibiting the
… do work in different ways from standard chemotherapy drugs treatment like attacking cancer …
… do work in different ways from standard chemotherapy drugs treatment like attacking cancer …
Strategies and approaches of targeting STAT3 for cancer treatment
SL Furtek, DS Backos, CJ Matheson… - ACS chemical …, 2016 - ACS Publications
… STAT3 inhibitors organized by the approach used to inhibit … A number of small molecule
compounds directly inhibit the … However, methods surrounding dosing with compounds remain …
compounds directly inhibit the … However, methods surrounding dosing with compounds remain …
相关搜索
- multi-target drugs cancer treatment
- cancer therapy stat3 inhibitors
- melatonin in cancer treatment
- implications for cancer therapy
- tyrosine kinase inhibitor in cancer treatment
- inhibitor agent cervical cancer treatment
- egfr inhibitor cancer treatment
- curcumin compounds cancer treatment
- virtual screening methods cancer treatment
- potential agents for cancer therapy
- long journey cancer treatment
- cancer therapy cardiac glycosides
- clinical trials cancer treatment
- cancer therapy medicinal prospects of antioxidants
- mtor inhibitors cancer treatment
- bioactive compounds cancer treatment